News
Sports
Life
Opinion
Business
Advertise
Obituaries
eNewspaper
Legals
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
NewsOK Local Stocks
NewsOK Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Xeris Pharmaceuticals Inc
(NQ:
XERS
)
2.895
+0.015 (+0.52%)
Streaming Delayed Price
Updated: 12:31 PM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Xeris Pharmaceuticals Inc
< Previous
1
2
3
4
Next >
More Than $20M Bet On Precigen? Check Out These 3 Stocks Under $5 Insiders Are Aggressively Buying
August 14, 2024
Via
Benzinga
Xeris Biopharma And 2 Other Penny Stocks Insiders Are Buying
August 13, 2024
Via
Benzinga
XERS Stock Earnings: Xeris Biopharma Holdings Beats EPS, Beats Revenue for Q2 2024
August 08, 2024
XERS stock results show that Xeris Biopharma Holdings beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
May 30, 2024
Via
Benzinga
Socket Mobile And 3 Other Stocks Under $3 Insiders Are Buying
May 13, 2024
Via
Benzinga
Earnings Outlook For Xeris Biopharma Holdings
March 05, 2024
Via
Benzinga
Why Xeris Biopharma Shares Are Trading Higher Today
October 16, 2023
Xeris Biopharma Holdings Inc (NASDAQ: XERS) shares are trading higher by around 9% after the
Via
Benzinga
Earnings Outlook For Xeris Biopharma Holdings
August 07, 2023
Via
Benzinga
Xeris Pharmaceuticals's Earnings Outlook
March 07, 2023
Via
Benzinga
XERS Stock Earnings: Xeris Biopharma Holdings Misses EPS, Misses Revenue for Q1 2024
May 09, 2024
XERS stock results show that Xeris Biopharma Holdings missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Why Are Xeris Biopharma Shares Moving Monday?
May 06, 2024
Xeris Biopharma shares are up Monday after the company announced an exclusive worldwide collaboration and license agreement with Beta Bionics. Xeris said it will work with Beta Bionics to develop and...
Via
Benzinga
XERS Stock Earnings: Xeris Biopharma Holdings Meets EPS, Beats Revenue for Q4 2023
March 06, 2024
XERS stock results show that Xeris Biopharma Holdings met analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 10, 2024
Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results.
Via
Benzinga
Earnings Scheduled For March 6, 2024
March 06, 2024
Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million.
Via
Benzinga
Morgan Stanley Block Sale Sends Chewy (CHWY) Stock Down
January 10, 2024
Chewy stock is falling on Wednesday after it was announced that Morgan Stanley is handling a block sale of CHWY shares.
Via
InvestorPlace
Why Is Xeris Biopharma (XERS) Stock Up 12% Today?
January 10, 2024
Xeris Biopharma stock is rising higher on Wednesday as investors in XERS shares react to a new exclusive worldwide license agreement.
Via
InvestorPlace
7 Small-Cap Stocks to Best Position Your Portfolio for a Strong 2024
January 08, 2024
Small cap stocks are anticipated to rise by as much as 50% in 2024 as investors look for growth in new areas of the market.
Via
InvestorPlace
Lamb Weston Posts Upbeat Results, Joins Omega Therapeutics, Allstate And Other Big Stocks Moving Higher On Thursday
January 04, 2024
U.S. stocks traded mostly higher, with the Dow Jones index gaining around 150 points on Thursday. Shares of Lamb Weston Holdings, Inc. (NYSE: LW) rose during Thursday’s session following...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Earnings Scheduled For November 9, 2023
November 09, 2023
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 28, 2023
August 28, 2023
Via
Benzinga
$8M Bet On Vicarious Surgical? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
August 10, 2023
The Dow Jones closed lower by around 200 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
BioXcel Therapeutics, Alvotech And Other Big Stocks Moving Lower On Thursday
June 29, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Thursday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
January 04, 2023
On Wednesday, 35 companies reached new 52-week lows.
Via
Benzinga
Earnings Scheduled For November 9, 2022
November 09, 2022
Companies Reporting Before The Bell • GCM Grosvenor (NASDAQ:GCMG) is likely to report quarterly earnings at $0.11 per share on revenue of $103.46 million.
Via
Benzinga
Earnings Scheduled For May 9, 2023
May 09, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.17 per share on revenue of $440.16 million.
Via
Benzinga
10 Best Medical Stocks Under $5
October 29, 2022
The medical industry is one of the most lucrative sectors globally, and it is one that sees the highest spending in terms of research and development, and breakthrough advances through keeping up the...
Via
Talk Markets
Earnings Scheduled For March 8, 2023
March 08, 2023
Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
January 05, 2023
On Thursday, 63 companies set new 52-week lows.
Via
Benzinga
Xeris Biopharma Posts Encouraging Data From Reformulated Thyroid Hormone Deficiency Treatment In Healthy Participants
October 20, 2022
Via
Benzinga
121 Stocks That Hit Their 52-Week Low
October 14, 2022
New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 121 stocks hit new 52-week lows.
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.